SecBot SecBot
SECBOTREPLAY Home › Report › CC

CC · Chemours Q2 2026 Adjusted EPS of $0.42 matched consensus, but revenue…

The Chemours Company · PRESS-RELEASE filed Aug 4, 2026 at 16:30 ET

At the news

NEUTRALIMPACT 4/10

PRESS-RELEASE filed Aug 4, 2026 at 16:30 ET

Chemours Q2 2026 Adjusted EPS of $0.42 matched consensus, but revenue of $1.591B missed the $1.66B estimate by ~4%. Adjusted EBITDA declined 5% YoY to $247M, and Q3 EBITDA guidance of $175-205M signals a sequential drop. Full-year guidance was maintained, but the weak Q3 outlook and revenue miss temper any positive read-through from in-line earnings.

  • Adjusted EPS $0.42 exactly in line with consensus estimate of $0.42
  • Revenue $1.591B missed consensus of $1.66B by ~4% ($69M shortfall)
  • Q3 2026 Adjusted EBITDA guidance $175-205M, well below Q2 2026 actual of $247M
  • Full-year 2026 EBITDA guidance maintained at $775-825M, implying modest H2 recovery

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access